Connecting you to content on EBSCOhost

Works matching AU Sodha, Nayanta

Results: 5

1

Low-penetrance susceptibility to breast cancer due to CHEK2<sup>*</sup>1100delC in noncarriers of BRCA1 or BRCA2 mutations.

Published in:

Nature Genetics, 2002, v. 31, n. 1, p. 55

By:

Meijers-Heijboer, Hanne;
van den Ouweland, Ans;
Klijn, Jan;
Wasielewski, Marijke;
de Snoo, Anja;
Oldenburg, Rogier;
Hollestelle, Antoinette;
Houben, Mark;
Crepin, Ellen;
van Veghel-Plandsoen, Monique;
Elstrodt, Fons;
van Duijn, Cornelia;
Bartels, Carina;
Meijers, Carel;
Schutte, Mieke;
McGuffog, Lesley;
Thompson, Deborah;
Easton, Douglas F.;
Sodha, Nayanta

Publication type:

Article

2

CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?

Published in:

Nature Reviews Cancer, 2007, v. 7, n. 12, p. 925, doi. 10.1038/nrc2251

By:

Antoni, Laurent;
Sodha, Nayanta;
Collins, Ian;
Garrett, Michelle D.

Publication type:

Article

3

Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndrome.

Published in:

Human Mutation, 2002, v. 20, n. 6, p. 460, doi. 10.1002/humu.10136

By:

Sodha, Nayanta;
Houlston, Richard S.;
Bullock, Sarah;
Yuille, Martin A.;
Chu, Carol;
Turner, Gwen;
Eeles, Rosalind A.

Publication type:

Article

4

A robust method for detecting CHK2/RAD53 mutations in genomic DNA.

Published in:

Human Mutation, 2002, v. 19, n. 2, p. 173, doi. 10.1002/humu.10031

By:

Sodha, Nayanta;
Houlston, Richard S.;
Williams, Richard;
Yuille, Martin A.;
Mangion, John;
Eeles, Rosalind A.

Publication type:

Article

5

Overexpression of RAD51 occurs in aggressive prostatic cancer.

Published in:

Histopathology, 2009, v. 55, n. 6, p. 696, doi. 10.1111/j.1365-2559.2009.03448.x

By:

Mitra, Anita;
Jameson, Charles;
Barbachano, Yolanda;
Sanchez, Lydia;
Kote-Jarai, Zsofia;
Peock, Susan;
Sodha, Nayanta;
Bancroft, Elizabeth;
Fletcher, Anne;
Cooper, Colin;
Easton, Douglas;
Eeles, Rosalind;
Foster, Christopher S.

Publication type:

Article